Kalaris Therapeutics (KLRS) P/E (2020 - 2026)
Kalaris Therapeutics (KLRS) P/E from Jul 30, 2020 to Jul 20, 2026. The TTM Kalaris Therapeutics (KLRS) P/E is -1.86. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Kalaris Therapeutics (KLRS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.86 | -51.00% |
| 2025 | -3.79 | +741.06% |
| 2024 | -0.45 | +8.57% |
| 2023 | -0.42 | -77.84% |
| 2022 | -1.88 | -60.52% |
| 2021 | -4.75 | -85.78% |
| 2020 | -33.40 | N/A |
Comparison Kalaris Therapeutics (KLRS) P/E with competitors
Kalaris Therapeutics (KLRS) P/E is -1.86.